Overactive Bladder (OAB) Therapeutics Market to Witness Robust Growth by 2026

The Overactive Bladder (OAB) Therapeutics Market, By Therapy (Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Others), By Disease Type (Idiopathic Overactive Bladder, Neurogenic Overactive Bladder), and Region - COVID-19 Impact Analysis and Forecast to 2026.

What is overactive bladder?

Overactive bladder (OAB) may be a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency. The common symptoms of OAB include high urinary frequency, urgency, and urinary incontinence. These drugs act by antagonizing cholinergic receptors that provide relief from frequent urination. 

Key Players

Key players operating in the Overactive Bladder (OAB) Therapeutics market are-

• Allergan PLC (US)
• Astellas Pharma Inc. (Japan)
• Cogentix Medical Inc. (US)
• Endo International PLC (Ireland)
• Hisamitsu Pharmaceutical Co. Inc. (Japan)
• Johnson & Johnson (US)
• Medtronic PLC (Ireland)
• Pfizer Inc. (US)
• Sanofi (France)
• Teva Pharmaceutical Industries Limited (Israel).

Market Dynamics

Growing incidence of diseases, such as Parkinson’s disease, which leads to overactive bladder disorder, and rising geriatric population, are key factors propelling the market growth. Urinary incontinence generally rises with aging. OAB has a major negative impact on the quality of life and health of the aged population. With the rising burden of OAB, coupled with other urinary diseases, the growth of the overactive bladder treatment market is expected to be high. Other factors, such as the development of innovative intravesical therapies and aggressive marketing by pharmaceutical companies, are anticipated to offer lucrative growth opportunities.

Want to get know more details of this report, Click here: https://www.stratviewresearch.com/2276/Overactive-Bladder-(OAB)-Therapeutics-Market.html

Share your requirements at -

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176

About Stratview Research:

Stratview Research is a credible source for gaining market intelligence to exponentially accelerate the user’s business. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.

Article source: https://article-realm.com/article/Finance/33003-Overactive-Bladder-OAB-Therapeutics-Market-to-Witness-Robust-Growth-by-2026.html